Cloud Hosting

September 6, 2023 10:20 AM | 4 min read

Massive returns are possible within this market! For a limited time, get access to the Benzinga Insider Report, usually $47/month, for just $0.99! Discover extremely undervalued stock picks before they skyrocket! Time is running out! Act fast and secure your future wealth at this unbelievable discount! Claim Your $0.99 Offer NOW!

Advertorial

Stakeholders in the biopharmaceutical industry are currently exploring the implementation of quantum computing in order to expedite the drug discovery process and cut down the overall R&D capital investment

LONDON , Sept. 6, 2023 /PRNewswire/ --Roots Analysishas announced the addition of "Quantum Computing Marketin Drug Discovery, 2023-2035" report to its list of offerings.

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Owing to the various benefits of quantum computing, such as big data processing and complex molecular modeling for minimizing cost and time investment, the adoption rate of quantum computing in pharmaceutical industry is expected to increase rapidly during the forecast period. Additionally, various partnerships have been inked for application of quantum computing in drug discovery. Majority of these partnerships are research and development agreements, followed by platform utilization agreements. Drug developers require support from both quantum computing software and hardware developers. In July 2021, Riverlane and Astex Pharmaceuticals announced their collaboration with Rigetti Computing to utilize their quantum systems along with Riverlane's algorithm expertise to develop molecular models of chemical compounds and study their interaction with proteins in the human body.

To order this 170+ slide report, which features 30+ figures and 75+ tables, please visit our Quantum Computing Market Report

Key Market Insights

For additional details, please visit

https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html

The financial opportunity within the quantum computing in drug discovery services market has been analysed across the following segments:

The research also includes detailed profiles of the key players (listed below) engaged in the quantum computing in drug discovery services market; each profile features an overview of the company, its financial information (if available), details related to its service portfolio, and recent developments and an informed future outlook.

Hidden gems are waiting to be found in this market! Don't miss the Benzinga Insider Report, typically $47/month, now ONLY $0.99! Uncover incredibly undervalued stocks before they soar! Limited time offer! Secure your financial success with this unbeatable discount! Grab your 0.99 offer TODAY!

Advertorial

Key Questions Answered

Table of Contents

For additional details, please visit https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

Contact:Gaurav Chaudhary +1 (415) 800 3415+44 (122) 391 1091gaurav.chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-quantum-computing-in-drug-discovery-services-market-is-anticipated-to-grow-at-14-cagr-by-2035-according-to-a-market-research-report-by-roots-analysis-301916995.html

SOURCE Roots Analysis

Massive returns are possible within this market! For a limited time, get access to the Benzinga Insider Report, usually $47/month, for just $0.99! Discover extremely undervalued stock picks before they skyrocket! Time is running out! Act fast and secure your future wealth at this unbelievable discount! Claim Your $0.99 Offer NOW!

Advertorial

2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read more:
The quantum computing in drug discovery services market is anticipated to grow at 14% CAGR by 2035, accor - Benzinga